ロード中...
Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of (1)H-NMR Spectroscopy and Gas Chromatography–Mass Spectrometry
Previous work demonstrated that serum metabolomics can distinguish pancreatic cancer from benign disease. However, in the clinic, non-pancreatic periampullary cancers are difficult to distinguish from pancreatic cancer. Therefore, to test the clinical utility of this technology, we determined whethe...
保存先:
| 出版年: | Metabolites |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5372206/ https://ncbi.nlm.nih.gov/pubmed/28098776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo7010003 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|